Login to Your Account

Nektar Prices $100M In Notes As It Moves Programs Forward

By Aaron Lorenzo

Friday, June 27, 2003

Drug delivery firm Nektar Therapeutics priced its offering of $100 million in notes reported earlier this week.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription